Consuming omega-3 fatty acids like flaxseed oil and walnuts may help slow the decline in physical function related to amyotrophic lateral sclerosis (ALS), new research suggests. ALS (formerly known as Lou Gehrig’s disease) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. People with ALS lose the ability to initiate and control muscle movement over time. The average life span after diagnosis is two to five years. A slower decline in symptoms may also slightly extend survival for people with ALS, the researchers noted. The new study findings were published online June 21 in the journal Neurology. “The link our study found between diet and ALS is intriguing and suggests, but does not prove, that people with ALS may benefit from incorporating more omega-3 fatty acids into their diet,” said Dr. Kjetil Bjornevik, an assistant professor of epidemiology and nutrition at Harvard T.H. Chan School of Public Health, in Boston. “It will now be important to conduct additional research looking specifically at the plant-based omega-3 fatty acid alpha-linolenic acid in people with ALS to further explore this possibility,” Bjornevik said in a journal news release. Besides flaxseed oil and walnuts, good sources of omega-3 fatty acids include canola oil and pumpkin seeds. Consuming more omega-6 fatty acid could also be beneficial, the investigators found. To study the link between…  read on >  read on >

The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up. The approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) provide a new class of medications for pediatric type 2 diabetes. They join metformin, which has been approved for children with type 2 diabetes since 2000. “Compared to adults, children with type 2 diabetes have limited treatment options, even though the disease and symptom onset generally progress more rapidly in children,” Dr. Michelle Carey, associate director for therapeutic review for the division of diabetes, lipid disorders and obesity in the FDA’s Center for Drug Evaluation and Research, said in an agency news release. “Today’s approvals provide much-needed additional treatment options for children with type 2 diabetes.” Type 2 diabetes is a chronic, progressive condition in which the body does not make or use insulin normally. Type 2 diabetes in children increased by 4.8% per year from 2002 to 2015, according to the SEARCH for Diabetes in Youth study. That number could reach 220,000 by 2060 if trends continue. The majority of cases are occurring in minority racial and ethnic groups. Before the approval, the active ingredient in both medications was tested for safety and effectiveness in a double-blind, randomized trial that included 157…  read on >  read on >

(HealthDay News) – The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration. In a statement, the company said it is telling these med spas, weight loss clinics and compounding pharmacies “to cease and desist from false advertising, trademark infringement and/or unlawful sales of non-FDA approved compounded products claiming to contain semaglutide.” Novo Nordisk makes the weight loss drug Wegovy and the diabetes drugs Ozempic and Rybelsus, and semaglutide is the key ingredient in those medications. “These unlawful marketing and sales practices … have created a high risk of consumer confusion and deception as well as potential safety concerns,” Novo Nordisk said. “Compounded products do not have the same safety, quality and effectiveness assurances as our FDA-approved drugs and may expose patients to health risks,” the company said. “Novo Nordisk cannot validate the safety or effectiveness of products claiming to contain semaglutide that are not one of our own branded products. Novo Nordisk is the only company in the U.S. with FDA-approved products containing semaglutide, and no FDA-approved generic versions of semaglutide currently exist.” In May, the FDA also warned customers about these alternate products and the compounding of these medications, noting that people…  read on >  read on >

You could have high blood pressure and not realize it. The only way to know for sure is to have your blood pressure tested. It’s an important step, according to the American Heart Association (AHA), and so is understanding your results so you can keep your blood pressure under control. A diagnosis of high blood pressure — and any unusually low blood pressure readings – must be made by a health care professional. Blood pressure readings have two numbers. Systolic blood pressure is the upper number and tells you how much pressure your blood is exerting against your artery walls when the heart contracts. The diastolic blood pressure is the lower number and it reveals the pressure your blood is exerting against your artery walls while the heart muscle rests between its contractions, the AHA said. Although either number can be used to diagnose high blood pressure, the systolic blood pressure is more notable and can be a major risk factor for cardiovascular disease for people over 50. That number typically rises steadily with age because large arteries stiffen and there is long-term buildup of plaque and an increased incidence of cardiac and vascular disease, the AHA said. Here are the five blood pressure ranges: American Heart Association The five blood pressure ranges are normal, elevated, hypertension stage 1, hypertension stage 2 and hypertensive crisis.…  read on >  read on >

Jeremy Davis made sure his wife, Chloe, got lots of support when she was breastfeeding each of their three sons. “When she’d been up nursing all night, I’d take over with the baby in the mornings so she could get extra sleep,” the Wilton, Conn., man recalled. Davis also learned to give special breastfeeding massages to help with milk flow and took on middle-of-the-night diaper duty. Now, a new survey finds that all this help from dad can set mom and baby up for success. When dads wanted their infant’s mother to breastfeed, moms were more likely to do so and to do so for longer periods. In addition, dads can help promote safe sleeping practices such as placing the baby on its back to prevent sudden infant death syndrome (SIDS). “Fathers make major contributions to the health of their families by supporting breastfeeding and adhering to safe sleep practices,” said study author Dr. John James Parker. He is an instructor of pediatrics at Northwestern University Feinberg School of Medicine, a pediatrician at Lurie Children’s, and an internist at Northwestern Medicine in Chicago. “Fathers are an important audience for health promotion campaigns, and clinicians and health care providers need to engage fathers and discuss all the ways that fathers can be helpful with an infant,” Parker added. For the study, Parker and his colleagues surveyed…  read on >  read on >

An advisory panel to the U.S. Food and Drug Administration voted unanimously on Thursday to recommend that COVID booster shots be updated for the fall to protect solely against one of the three XBB variants that have taken hold in the United States. Those three XBB variants, which are all sublineages of the Omicron variant, are XBB.1.5, XBB.1.16 and XBB.2.3, CNN reported. What will be dropped from the updated vaccines will be protection against the original strain of the virus because experts believe it could contribute to lower vaccine efficacy against newer strains. “Your immune response likes to react to what it’s seen before,” Dr. David Ho, a professor of microbiology and immunology at Columbia University whose research was cited in FDA briefing documents, told CNN. “That’s why we made the recommendation that if you want to broaden out your antibody responses, it’s best to remove the ancestral spike in future vaccines,” Ho explained. Although the FDA will make the final decision on the updated vaccines, it typically follows the advice of its advisory panels. While infections have declined across the United States, the virus could be a concern next winter, the FDA’s vaccine chief Dr. Peter Marks said as the daylong meeting began, the Associated Press reported. “We’re concerned that we may have another wave of COVID-19 during a time when the virus has…  read on >  read on >

Intermittent fasting is all the rage due to the lengthy list of health benefits associated with this style of eating. Now, a new, small study suggests that one type of intermittent fasting — early time-restricted eating — may be key for preventing type 2 diabetes in people who are at high risk for the blood sugar disease. The study included 10 people with prediabetes and obesity. Prediabetes refers to when blood sugar levels are higher than normal but not high enough to be defined as diabetes. Obesity is also considered a major risk factor for type 2 diabetes. Folks in the study ate 80% of their daily calories before 1 p.m (early time-restricted feeding) or half of their calories after 4 p.m (usual eating) for one week, and then they switched to the opposite group during the second week. Early time-restricted feeding reduced blood sugar fluctuations and decreased the time that blood sugar was above normal levels throughout the day, and this was independent of any weight loss. “There is a large body of evidence that eating early in the day is beneficial for metabolic health, and many people experience weight loss even though their calories may not be restricted, but it was unclear whether these benefits were related to weight loss or independent, and this study suggests they are independent,” said study author Dr.…  read on >  read on >

While food allergies have not historically been top of mind for racial and ethnic minorities, new research shows that Hispanic, Black and Asian communities all face a higher prevalence of these issues. Money also mattered: In households where incomes were higher, at more than $150,000 a year, food allergies were less prevalent. “Food allergies are not frequently talked about impacting racial and ethnic communities,” said study co-author Dr. Ruchi Gupta, director of the Center for Food Allergy and Asthma Research and a professor of pediatrics at Northwestern University Feinberg School of Medicine in Chicago. “It’s not on the radar. But we now know it does impact them more, and it’s important to improve awareness.” “It is also critical to improve access to diagnosis and treatments for food allergy,” Gupta said in a university news release. “It is an exciting time with new treatments, and it’s essential to make sure they reach racial and ethnic minorities who have higher rates of food allergy.” For the study, the researchers administered a survey online and via telephone to a nationally representative sample of the U.S. population, including more than 50,000 households with responses for nearly 80,000 individuals. The survey was given from October 2015 to September 2016. Food allergy affects 11% of adults and 8% of children in the United States. The study found that prevalence of food…  read on >  read on >

Regulators want your next tattoo to be as safe as it is trendy. The U.S. Food and Drug Administration has issued a draft of new guidance aimed at helping manufacturers and distributors of tattoo inks prevent microbial contamination. “With about 30% of people living in the U.S. having a tattoo, it’s imperative that the FDA take all necessary steps to help ensure that tattoo inks are free of contamination,” said FDA Chief Scientist Namandjé Bumpus. “Pathogens or other harmful substances in these inks can cause infections and serious injuries,” she said in an agency news release. “The FDA is issuing this draft guidance to help tattoo ink manufacturers and distributors recognize situations in which tattoo ink may become contaminated with microorganisms and take steps to protect public health.” The FDA issued a safety alert on tattoo inks in May 2019. It advised consumers, tattoo artists and retailers to avoid using or selling certain tainted inks. Many people have reported to federal regulators illness caused by contaminated tattoo inks. Testing has found that many sealed tattoo inks in the United States have microbial contamination. “Unlike most cosmetics, tattoo inks are injected into the dermal layer of the skin, and therefore have the potential to introduce harmful pathogens directly into the body. Because of this, it is particularly important for tattoo inks to be manufactured using methods…  read on >  read on >

COVID-19 boosters may be offered this fall, but first scientists need to determine what strains to target and who should receive the shots. Advisers to the U.S. Food and Drug Administration are slated to meet Thursday to discuss plans for fall, a decision with a deadline because drugmakers will need to have the time to manufacture the shots, NBC News reported. The process is similar to deciding on an annual flu vaccine. FDA scientists said redesigned boosters should target at least one variant of XBB, according to briefing documents published Monday. XBB strains have been spreading since last fall and are related to an omicron subvariant. “These data suggest that an updated strain composition of COVID-19 vaccines to more closely match currently circulating omicron sublineages is warranted for the 2023-2024 vaccination campaign,” the scientists wrote. The World Health Organization and the European Medicines Agency have both said a booster should target an XBB subvariant. As the virus has changed, vaccines have evolved, from a shot in December 2020 that targeted the original virus to FDA-approved shots last fall that targeted the original COVID strain as well as the omicron subvariants BA.4 and BA.5. XBB 1.5 is the dominant strain now circulating, with 40% of new cases having this strain, according to the U.S. Centers for Disease Control and Prevention. About 18% of new cases have…  read on >  read on >